“Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants,” the WHO said in a medical product alert, warning that while the contested products had so far been found in The Gambia, they could have been distributed to other countries.